Cawson M, Wolowacz S, Doward L, Sinha A. Health utility estimates for congenital cytomegalovirus disease: conceptual design considerations. Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Samuelson T, Singh IP, Katz LJ, Falvey H, Odom D, McSorley D. Effect of iStent inject trabecular micro-bypass on patient-reported outcomes for those with open-angle glaucoma and coexisting cataracts. Poster presented at the ISPOR 2019 European Conference; November 6, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Millar (Gildea) L, Stevenson A, Carter K. NICE medical technologies guidance - impact beyond the UK. Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Twiss J, Whalley D, Doward L, Balp MM, Brass C, Lopez P, Loeffler J, Cai J, Cryer D, Sanyal AJ, Anstee QM. Psychometric evaluation of NASH-CHECK, a patient-reported outcome measure for Nonalcoholic Steatohepatitis. Poster presented at the ISPOR 2019 European Conference; November 6, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Aronsson M, Ling C, Stevenson A, Brodtkorb TH. Submission process and requirements of Nordic health technology assessment (HTA) authorities for hospital drugs - implications for market access strategy. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Pearson I, Stevenson A, Krieger T, Ling C. What is the role of the company evidence submission in National Institute for Health and Care Excellence (NICE) multiple technology appraisals? Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Heyes A, Millar (Gildea) L. Early dialogue with NICE and EUnetHTA: a UK perspective in a politically uncertain era. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Mansfield C, Poulos C, Boeri M, Hauber B. Performance of a comprehension question in discrete-choice experiment surveys (DCE). Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Barrett A, Hahn-Pedersen J, Kragh N, Evans E, Gnanasakthy A. Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Zhang Y, Herring WL, Martin A, Gunsoy N, Zhang W. Development of a novel economic modeling approach for asthma. Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Crawford SR, Morrison R, Doward L. The rise of the social media machine - a review of patient-centered research utilizing social media research methods presented at ISPOR (2010 -2018). Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3). doi: 10.1016/j.jval.2019.09.2281
Gallagher J, Russell L, McAlister M, Brockbank J. Impact of gemtuzumab ozogamicin on the Irish healthcare system. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Rasouliyan L, Martinez D. The effect modification problem: using stratified matching adjusted indirect comparison to evade misleading interpretations of the treatment effect. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Richardson D, Zhan L, Reynolds M, Odom D, McRoy L, Mitra D, Zelnak A, Jones C. Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer: data from the Madeline study. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(SE).
Ervin C, Thach A, Lee A, Navia B, Evans E, Doward L. Refinement of the treatment preference questionnaire in adults with Parkinson's Disease and off-episodes. Poster presented at the ISPOR 2019 European Conference; November 6, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Nov; 22(S3):S756. doi: 10.1016/j.jval.2019.09.1870
Poulos C, Soliman AM, Renz CL, Posner J, Agarwal SK. Patient preferences for endometriosis pain treatments in the United States. Value Health. 2019 Jun;22(6):728-38. doi: 10.1016/j.jval.2018.12.010
Zhang K, Huang SP, Touchette D, Marko-Holguin M, Van Voorhees B. Cost-effectiveness of web-based depression programs for adolescents. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 2019. New Orleans, LA. [abstract] Value Health. 2019 May; 22(Suppl 2):S227. doi: 10.1016/j.jval.2019.04.1055
Mauskopf J, Herring W, Zhang Y, Tahami A. The variability in structural assumptions in models estimating the effectiveness of hypothetical disease modifying treatment for Alzheimer's disease. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA. [abstract] Value Health. 2019 May; 22(Supplement 2):S272.
Ronquest NA, Gould IG, Barnett CL, Mladsi DM. A systematic review of ICER evaluations from 2008 to 2018: recent trends in evaluation process and lessons learned. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA. [abstract] Value Health. 2019 May; 22(2):S263-4.
Korgaonkar S, Gangan N, Banahan III B, Pittman E, Kirby T, Noble S. Impact of diverse inclusion criteria on assessment of HEDIS Asthma Medication Ratio (AMR) quality measure in Mississippi Medicaid. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 18, 2019. New Orleans, LA. [abstract] Value Health. 2019 May; 22(S1):S358.
Korgaonkar S, Yang Y. Impact of occupational psychosocial risk factors on frequent, severe low back pain in the US working population. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 18, 2019. New Orleans, LA. [abstract] Value Health. 2019 May; 22(S2):S244-5.
Gould I, Herring W, Benninghoff B, Standaert B. Explaining the rotavirus serotype-distribution shift in children after vaccination using a simple transmission model. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA. [abstract] Value Health. 2019 May; 22(Supplment 2):S202-3.
Gnanasakthy A, Barrett A, Evans E, D'Alessio D, Romano (DeMuro) C. A review of patient-reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012-2016). Value Health. 2019 Feb;22(2):203-9. doi: 10.1016/j.jval.2018.09.2842